Frailty, osteoporosis and hip fracture: Causes, consequences and therapeutic perspectives

Abstract

Objective: The aim of this review of the literature is to report the factors which both contribute to the frailty syndrome and increase hip fracture risk in the elderly. This work is the fruit of common reflection by geriatricians, endocrinologists, gynecologists and rheumatologists, and seeks to stress the importance of detection and management of the various components of frailty in elderly subjects who are followed and treated for osteoporosis. It also sets out to heighten awareness of the need for management of osteoporosis in the frail elderly.Design: The current literature on frailty and its links with hip fracture was reviewed and discussed by the group.Results: The factors and mechanisms which are common to both osteoporosis and frailty (falls, weight loss, sarcopenia, low physical activity, cognitive decline, depression, hormones such as testosterone, estrogens, insulin-like growth factor-I (IGF-I), growth hormone (GH), vitamin D and pro-inflammatory cytokines) were identified. The obstacles to access to diagnosis and treatment of osteoporosis in the frail elderly population and common therapeutic pathways for osteoporosis and frailty were discussed.Conclusion: Future research including frail subjects would improve our understanding of how management of frailty can can contribute to lower the incidence of fractures. In parallel, more systematic management of osteoporosis should reduce the risk of becoming frail in the elderly population.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Mitnitski AB, Mogilner AJ, MacKnight C, Rockwood K. The accumulation of deficits with age and possible invariants of aging. ScientificWorldJournal. 2002 Jun 28;2: 1816–22.

    PubMed  Google Scholar 

  2. 2.

    Fried LP, Walston J. Frailty and failure to thrive. In: W.R. Hazzard, J.P. Blass, J.B. Halter et al. editor. Principles of geriatric medicine and gerontology. USA: McGraw Hill, 2003;1487–1502.

    Google Scholar 

  3. 3.

    Lipsitz LA, Goldberger AL. Loss of ‘complexity’ and aging. Potential applications of fractals and chaos theory to senescence. JAMA. 1992 Apr l;267(13): 1806–9.

    PubMed  CAS  Google Scholar 

  4. 4.

    Bortz WM 2nd. The physics of frailty. J Am Geriatr Soc. 1993 Sep;41(9): 1004–8.

    PubMed  Google Scholar 

  5. 5.

    Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3): M146–56.

    PubMed  CAS  Google Scholar 

  6. 6.

    Hogan DB, MacKnight C, Bergman H, on behalf of the steering committee Canadian Initiative on Frailty and Aging. Models, definitions, and criteria of frailty. Aging Clin Exp Res. 2003;15(3 Suppl): l-29.

    Google Scholar 

  7. 7.

    Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD; Interventions on Frailty Working Group. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc. 2004 Apr;52(4): 625–34.

    PubMed  Google Scholar 

  8. 8.

    Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, Ershler WB, Harris T, Fried LP. Research agenda for frailty in older adults: towards a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research conference on frailty in older adults. J Am Geriatr Soc 2006;54: 991–1001.

    PubMed  Google Scholar 

  9. 9.

    Bergman H, Ferrucci L, Guralnik J, Hogan DB, Hummel S, Karunananthan S, Wolfson C. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7): 731–7.

    PubMed  Google Scholar 

  10. 10.

    Morley JE, Perry HM, Miller DK. Something about frailty. J Gerontol Med Sci 2002 (57A);11: M698-M704.

    Google Scholar 

  11. 11.

    Rockwood K. Frailty and its definition: a worthy challenge. J Am Geriatr Soc 2005;53: 1069–1070.

    PubMed  Google Scholar 

  12. 12.

    Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med. 2006 Feb 27;166(4): 418–23.

    PubMed  Google Scholar 

  13. 13.

    Morley JE, Haren MT, Rolland Y, Kim MJ. Frailty. Med Clin North Am. 2006 Sep;90(5): 837–47.

    PubMed  Google Scholar 

  14. 14.

    van Iersel MB, Rikkert MG. Frailty criteria give heterogeneous results when applied in clinical practice. J Am Geriatr Soc 2006;54: 728–729

    PubMed  Google Scholar 

  15. 15.

    Crepaldi G, Maggi S. Sarcopenia and osteoporosis: A hazardous duet. J Endocrinol Invest. 2005;28(10 Suppl): 66–8.

    PubMed  CAS  Google Scholar 

  16. 16.

    Cuddihy MT, Gabriel SE, Crowson CS, O’Fallon WM, Melton LJ 3rd. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int. 1999;9: 469–75.

    PubMed  CAS  Google Scholar 

  17. 17.

    Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA. Hip fracture incidence among the old and very old: a population-based study of 745,435 cases. Am J Public Health. 1990 Jul;80(7): 871–3.

    PubMed  CAS  Google Scholar 

  18. 18.

    Todd CJ, Palmer C, Camilleri-Ferrante C, Freeman CJ, Laxton CE, Parker MJ, Payne BV, Rushton N. Differences in mortality after fracture of hip. BMJ. 1995 Oct 14;311(7011): 1025.

    PubMed  CAS  Google Scholar 

  19. 19.

    Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S; the HORIZON Recurrent Fracture Trial. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. N Engl J Med. 2007 Nov l;357(18): 1799–809.

    PubMed  CAS  Google Scholar 

  20. 20.

    Foster MR, Heppenstall RB, Friedenberg ZB, Hozack WJ. A prospective assessment of nutritional status and complications in patients with fractures of the hip. J Orthop Trauma. 1990;4(l): 49–57.

    PubMed  CAS  Article  Google Scholar 

  21. 21.

    Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol. 1990 May;45(3): M101–7.

    PubMed  CAS  Google Scholar 

  22. 22.

    Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA, Tracy JK, Hochberg MC, Rodondi N, Cawthon PM; for the Study of Osteoporotic Fractures Research Group. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7): 744–51.

    PubMed  Google Scholar 

  23. 23.

    Ferrucci L, Russo CR, Lauretani F, Bandinelli S, Guralnik JM. A role for sarcopenia in late-life osteoporosis. Aging Clin Exp Res. 2002 Feb;14(1): 1–4.

    PubMed  CAS  Google Scholar 

  24. 24.

    Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, Meunier PJ, Breart G. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet. 1996; Jul 20;348(9021): 145–9.

    PubMed  CAS  Google Scholar 

  25. 25.

    Greenspan SL, Myers ER, Kiel DP, Parker RA, Hayes WC, Resnick NM. Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med. 1998 Jun;104(6): 539–45.

    PubMed  CAS  Google Scholar 

  26. 26.

    Mautalen CA, Vega EM, Einhorn TA. Are the etiologies of cervical and trochanteric hip fractures different? Bone. 1996 Mar;18(3 Suppl): 133S-137S.

    PubMed  CAS  Google Scholar 

  27. 27.

    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; May 18;359(9319): 1761–7.

    PubMed  Google Scholar 

  28. 28.

    Runge M, Hunter G. Determinants of musculoskeletal frailty and the risk of falls in old age. J Musculoskelet Neuronal Interact. 2006 Apr–Jun;6(2): 167–73.

    PubMed  CAS  Google Scholar 

  29. 29.

    Sambrook PN, Cameron ID, Chen JS, Dimming RG, Lord SR, March LM, Schwarz J, Scibel MJ, Simpson JM. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int. 2007 May;18(5): 603–10.

    PubMed  CAS  Google Scholar 

  30. 30.

    Geusens P, Autier P, Boonen S, Vanhoof J, Declerck K, Raus J. The relationship among history of falls, osteoporosis, and fractures in postmenopausal women. Arch Phys Med Rehabil. 2002 Jul;83(7): 903–6.

    PubMed  Google Scholar 

  31. 31.

    Nevitt MC, Cummings SR. Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. The Study of Osteoporotic Fractures Research Group. J Am GeriatrSoc. 1993 Nov;41(11): 1226–34.

    CAS  Google Scholar 

  32. 32.

    Girman CJ, Chandler JM, Zimmerman SI, Martin AR, Hawkes W, Hebel JR, Sloane PD, Magaziner J. Prediction of fracture in nursing home residents. J Am Geriatr Soc. 2002 Aug;50(8): 1341–7.

    PubMed  Google Scholar 

  33. 33.

    Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, Delmas PD, Pouilles JM, Breart G, Meunier PJ. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet. 1996 Aug 24;348(9026): 511–4.

    PubMed  CAS  Google Scholar 

  34. 34.

    McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY; Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001 Feb 1;344(5): 333–40.

    PubMed  CAS  Google Scholar 

  35. 35.

    Schwartz AV, Nevitt MC, Brown BW Jr, Kelsey JL. Increased falling as a risk factor for fracture among older women: the study of osteoporotic fractures. Am J Epidemiol. 2005 Jan 15;161(2): 180–5.

    PubMed  Google Scholar 

  36. 36.

    Porter RW, Miller CG, Grainger D, Palmer SB. Prediction of hip fracture in elderly women: a prospective study. BMJ. 1990 Sep 29;301(6753): 638–41.

    PubMed  CAS  Google Scholar 

  37. 37.

    Rolland Y, Kim MJ, Gammack JK, Wilson MM, Thomas DR, Morley JE. Office management of weight loss in older persons. Am J Med. 2006 Dec;119(12): 1019–26.

    PubMed  Google Scholar 

  38. 38.

    Vanitallie TB. Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism. 2003 Oct;52(10 Suppl 2): 22–6.

    PubMed  Google Scholar 

  39. 39.

    Blain H, Carriere I, Favier F, Jeandel C, Papoz L; EPIDOS Study Group. Body weight change since menopause and percentage body fat mass are predictors of subsequent bone mineral density change of the proximal femur in women aged 75 years and older: results of a 5 year prospective study. Calcif Tissue Int. 2004 Jul;75(1): 32–9.

    PubMed  CAS  Google Scholar 

  40. 40.

    Orwoll ES, Weigel RM, Oviatt SK, Meier DE, McClung MR. Serum protein concentrations and bone mineral content in aging normal men. Am J Clin Nutr. 1987 Oct;46(4): 614–21.

    PubMed  CAS  Google Scholar 

  41. 41.

    Rico H, Revilla M, Villa LF, Hernandez ER, Fernandez JP. Crush fracture syndrome in senile osteoporosis: a nutritional consequence? J Bone Miner Res. 1992 Mar;7(3): 317–9.

    PubMed  CAS  Google Scholar 

  42. 42.

    Saito N, Tabata N, Saito S, Andou Y, Onaga Y, Iwamitsu A, Sakamoto M, Hori T, Sayama H, Kawakita T. Bone mineral density, serum albumin and serum magnesium. J Am Coll Nutr. 2004 Dec;23(6): 701S-3S.

    PubMed  CAS  Google Scholar 

  43. 43.

    Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med. 1987 Nov 5;317(19): 1169–74.

    PubMed  CAS  Google Scholar 

  44. 44.

    Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; Mar 23;332(12): 767–73.

    PubMed  CAS  Google Scholar 

  45. 45.

    Langlois JA, Visser M, Davidovic LS, Maggi S, Li G, Harris TB. Hip fracture risk in older white men is associated with change in body weight from age 50 years to old age. Arch Intern Med. 1998 May 11;158(9): 990–6.

    PubMed  CAS  Google Scholar 

  46. 46.

    Ensrud KE, Ewing SK, Stone KL, Cauley JA, Bowman PJ, Cummings SR; Study of Osteoporotic Fractures Research Group. Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women. J Am Geriatr Soc. 2003 Dec;51(12): 1740–7.

    PubMed  Google Scholar 

  47. 47.

    Greenspan SL, Myers ER, Mailland LA, Resnick NM, Hayes WC. Fall severity and bone mineral density as risk factors for hip fracture in ambulatory elderly. JAMA. 1994 Jan 12;271(2): 128–33.

    PubMed  CAS  Google Scholar 

  48. 48.

    Rosenberg IH. Summary comments. Am J Clin Nutr 1989;50: 1231–3.

    Google Scholar 

  49. 49.

    Nguyen T, Sambrook P, Kelly P, Jones G, Lord S, Freund J, Eisman J. Prediction of osteoporotic fractures by postural instability and bone density. BMJ. 1993 Oct 30;307(6912): 1111–5.

    PubMed  CAS  Google Scholar 

  50. 50.

    Bonnefoy M, Jauffret M, Jusot JF. Muscle power of lower extremities in relation to functional ability and nutritional status in very elderly people. J Nutr Health Aging. 2007;11: 223–8.

    PubMed  CAS  Google Scholar 

  51. 51.

    Joseph C, Kenny AM, Taxel P, Lorenzo JA, Duque G, Kuchel GA. Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med. 2005 Jun;26(3): 181–201.

    PubMed  CAS  Google Scholar 

  52. 52.

    Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Fiatarone-Singh MA. Longitudinal changes in body composition in older men and women: role of body weight change and physical activity. Am J Clin Nutr 2002;76: 473–81.

    PubMed  CAS  Google Scholar 

  53. 53.

    Evans W. Functional and metabolic consequences of sarcopenia. J Nutr. 1997;127: 998S-1003S.

    PubMed  CAS  Google Scholar 

  54. 54.

    Roubenoff R, Hughes VA. Sarcopenia. Current concepts. J Gerontol A Biol Sci Med Sci 2000;55A: M716-M724.

    CAS  Google Scholar 

  55. 55.

    Morley JE, Baumgartner RN, Roubenoff R et al. Sarcopenia. J Lab Clin Med. 2001;137: 231–243.

    PubMed  CAS  Google Scholar 

  56. 56.

    Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve. 2002;25: 17–25.

    PubMed  CAS  Google Scholar 

  57. 57.

    Janssen I, Baumgartner RN, Ross R et al. Skeletal muscle cutpoints associated with elevated physical disability risk in oldermen and women. Am J Epidemiol. 2004;159: 413–421.

    PubMed  Google Scholar 

  58. 58.

    Melton LJ 3rd, Khosla S, Riggs BL. Epidemiology of sarcopenia. Mayo Clin Proc. 2000 Jan;75 Suppl: S10–2.

    PubMed  Article  Google Scholar 

  59. 59.

    Rolland Y, Lauwers-Cances V, Cournot M, Nourhashemi F, Reynish W, Riviere D, Vellas B, Grandjean H. Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc. 2003 Aug;51(8): l120–4.

    Google Scholar 

  60. 60.

    Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998 Apr 15;147(8): 755–63.

    PubMed  CAS  Google Scholar 

  61. 61.

    Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002 May;50(5): 889–96.

    PubMed  Google Scholar 

  62. 62.

    Walsh MC, Hunter GR, Livingstone MB. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int. 2006 Jan;17(l): 61–7.

    PubMed  Google Scholar 

  63. 63.

    Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev. 1999 Mar 1;107(2): 123–36.

    PubMed  CAS  Google Scholar 

  64. 64.

    Baumgartner RN, Stauber PM, Koehler KM, Romero L, Garry PJ. Associations of fat and muscle masses with bone mineral in elderly men and women. Am J Clin Nutr. 1996 Mar;63(3): 365–72.

    PubMed  CAS  Google Scholar 

  65. 65.

    Gillette-Guyonnet S, Nourhashemi F, Lauque S, Grandjean H, Vellas B. Body composition and osteoporosis in elderly women. Gerontology. 2000 Jul-Aug;46(4): 189–93.

    PubMed  CAS  Google Scholar 

  66. 66.

    Pettersson U, Nordstrom P, Lorentzon R. A comparison of bone mineral density and muscle strength in young male adults with different exercise level. Calcif Tissue Int. 1999 Jun;64(6): 490–8.

    PubMed  CAS  Google Scholar 

  67. 67.

    Szulc P, Beck TJ, Marchand F, Delmas PD. Low skeletal muscle mass is associated with poor structural parameters of bone and impaired balance in elderly men-the MINOS study. J Bone Miner Res. 2005 May;20(5): 721–9.

    PubMed  Google Scholar 

  68. 68.

    Gentil P, Lima RM, Jaco de Oliveira R, Pereira RW, Reis VM. Association between femoral neck bone mineral density and lower limb fat-free mass in postmenopausal women. J Clin Densitom. 2007 Apr–Jun;10(2): 174–8.

    PubMed  Google Scholar 

  69. 69.

    Gutin B, Kasper MJ. Can vigorous exercise play a role in osteoporosis prevention? A review. Osteoporos Int 1992 Mar;2(2): 55–69.

    PubMed  CAS  Google Scholar 

  70. 70.

    Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA. 1987 Mar 20;257(11): 1492–5.

    PubMed  CAS  Google Scholar 

  71. 71.

    Morris JC, Rubin EH, Morris EJ, Mandel SA. Senile dementia of the Alzheimer’s type: an important risk factor for serious falls. J Gerontol. 1987 Jul;42(4): 412–7.

    PubMed  CAS  Google Scholar 

  72. 72.

    Oleske DM, Wilson RS, Bernard BA, Evans DA, Terman EW. Epidemiology of injury in people with Alzheimer’s disease. J Am Geriatr Soc. 1995 Jul;43(7): 741–6.

    PubMed  CAS  Google Scholar 

  73. 73.

    Melton LJ 3rd, Beard CM, Kokmen E, Atkinson EJ, O’Fallon WM. Fracture risk in patients with Alzheimer’s disease. J Am Geriatr Soc. 1994 Jun;42(6): 614–9.

    PubMed  Google Scholar 

  74. 74.

    Wang L, Larson EB, Bowen JD, van Belle G. Performance-based physical function and future dementia in older people. Arch Intern Med. 2006 May 22;166(10): 1115–20.

    PubMed  Google Scholar 

  75. 75.

    Larson EB, Wang L, Bowen JD, McCormick WC, Teri L, Crane P, Kukull W. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med. 2006 Jan 17;144(2): 73–81.

    PubMed  Google Scholar 

  76. 76.

    Fitzpatrick AL, Buchanan CK, Nahin RL, Dekosky ST, Atkinson HH, Carlson MC, Williamson JD; Ginkgo Evaluation of Memory (GEM) Study investigators. Association of gait speed and other measures of physical function with cognition in a healthy cohorte of elderly persons. J Gerontol A Biol Sci Med Sci. 2007 Nov;62(11)1244–51.

    PubMed  Google Scholar 

  77. 77.

    Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002 Dec;57(12): M772–7.

    PubMed  Google Scholar 

  78. 78.

    Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr. 2004 Aug;80(2): 496–503.

    PubMed  CAS  Google Scholar 

  79. 79.

    Leifke E, Korner HC, Link TM, Behre HM, Peters PE, Nieschlag E. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol. 1998 Jan;138(1): 51–8.

    PubMed  CAS  Google Scholar 

  80. 80.

    Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab. 1997 Aug;82(8): 2423–8.

    PubMed  CAS  Google Scholar 

  81. 81.

    ter Maaten JC, de Boer H, Kamp O, Stuurman L, van der Veen EA. Long-term effects of growth hormone (GH) replacement in men with childhood-onset GH deficiency. J Clin Endocrinol Metab. 1999 Jul;84(7): 2373–80.

    PubMed  Google Scholar 

  82. 82.

    Langlois JA, Rosen CJ, Visser M, Hannan MT, Harris T, Wilson PW, Kiel DP. Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. J Clin Endocrinol Metab. 1998 Dec;83(12): 4257–62.

    PubMed  CAS  Google Scholar 

  83. 83.

    Schedlich LJ, Muthukaruppan A, O’Han MK, Baxter RC. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Mol Endocrinol. 2007 Oct;21(10): 2378–90.

    PubMed  CAS  Google Scholar 

  84. 84.

    Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990 Jul 5;323(1): 1–6.

    PubMed  CAS  Google Scholar 

  85. 85.

    Thompson JL, Butterfield GE, Marcus R, et al. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab 1995; 80: 1845–1852.

    PubMed  CAS  Google Scholar 

  86. 86.

    Yarasheski KE, Zachwieja JJ, Campbell JA, Bier DM. Effect of growth hormone and resistance exercise on muscle growth and strength in older men. Am J Physiol Endocrinol Metab 1995; 268: E268–76.

    CAS  Google Scholar 

  87. 87.

    Papadakis MA, Grady D, Black D, et al. Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 1996; 124: 708–716.

    PubMed  CAS  Google Scholar 

  88. 88.

    Lange KH, Isaksson F, Rasmussen MH, et al. GH administration and discontinuation in healthy elderly men: effects on body composition, GH-related serum markers, resting heart rate and resting oxygen uptake. Clin Endocrinol. 2001; 55: 77–86.

    CAS  Google Scholar 

  89. 89.

    Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002; 288: 2282–2292.

    PubMed  CAS  Google Scholar 

  90. 90.

    Cannon JG. Cytokines in aging and muscle homeostasis. J Gerontol A Biol Sci Med Sci. 1995 Nov;50 Spec No:120-3.

  91. 91.

    Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R, Havlik RJ. Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc. 1999 Jun;47(6): 639–46.

    PubMed  CAS  Google Scholar 

  92. 92.

    Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med. 2006 Feb 27;166(4): 424–30.

    PubMed  CAS  Google Scholar 

  93. 93.

    Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA. 2005 May 11;293(18): 2257–64.

    PubMed  CAS  Google Scholar 

  94. 94.

    Ooms ME, Vlasman P, Lips P, Nauta J, Bouter LM, Valkenburg HA. The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int 1994 Jan;4(1): 6–10.

    PubMed  CAS  Google Scholar 

  95. 95.

    Duque G, Mallet L, Roberts A, Gingrass S, Kremer R, Sainte-Marie LG, Kiel DP; Quebec Symposium for the Treatment of Osteoporosis in Long-Term Care. To treat or not to treat, that is the question: proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-term Care Institutions, Saint-Hyacinthe, Quebec, November 5, 2004. J Am Med Dir Assoc. 2006 Sep;7(7): 435–41.

    PubMed  Google Scholar 

  96. 96.

    Papaioannou A, Kennedy CC, Ioannidis G, Gao Y, Sawka AM, Goltzman D, Tenenhouse A, Pickard L, Olszynski WP, Davison KS, Kaiser S, Josse RG, Kreiger N, Hanley DA, Prior JC, Brown JP, Anastassiades T, Adachi JD; CaMos Research Group. The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int. 2007 Oct 9

  97. 97.

    Kamel HK. Underutilization of calcium and vitamin D supplements in an academic long-term care facility. J Am Med Dir Assoc. 2004 Mar–Apr;5(2): 98–100.

    PubMed  Google Scholar 

  98. 98.

    Saliba D, Solomon D, Rubenstein L, Young R, Schnelle J, Roth C, Wenger N. Quality indicators for the management of medical conditions in nursing home residents. J Am Med Dir Assoc. 2005 May–Jun;6(3 Suppl): S36–48.

    PubMed  Google Scholar 

  99. 99.

    Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004 Oct;15(10): 767–78.

    PubMed  CAS  Google Scholar 

  100. 100.

    Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C. The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int. 2004 Dec;15(12): 1003–8.

    PubMed  Google Scholar 

  101. 101.

    Johansen A, Evans W, Stone M. Bone assessment in elderly women: what does a low bone ultrasound result tell us about bone mineral density? Arch Gerontol Geriatr. 1999 May–Jun;28(3): 239–46.

    PubMed  CAS  Google Scholar 

  102. 102.

    McLean RR, Hannan MT, Epstein BE, Bouxsein ML, Cupples LA, Murabito J, Kiel DP. Elderly cohort study subjects unable to return for follow-up have lower bone mass than those who can return. Am J Epidemiol. 2000 Apr 1;151(7): 689–92.

    PubMed  CAS  Google Scholar 

  103. 103.

    Lips P, Ooms ME. Non-pharmacological interventions. Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Jun;14(2): 265–77.

    PubMed  CAS  Google Scholar 

  104. 104.

    Haapasalo H, Kontulainen S, Sievanen H, Kannus P, Jarvinen M, Vuori I. Exercise-induced bone gain is due to enlargement in bone size without a change in volumetric bone density: a peripheral quantitative computed tomography study of the upper arms of male tennis players. Bone. 2000 Sep;27(3): 351–7.

    PubMed  CAS  Google Scholar 

  105. 105.

    Lynch NA, Ryan AS, Evans J, Katzel LI, Goldberg AP. Older elite football players have reduced cardiac and osteoporosis risk factors. Med Sci Sports Exerc. 2007 Jul;39(7): 1124–30.

    PubMed  Google Scholar 

  106. 106.

    Klein CS, Allman BL, Marsh GD, Rice CL. Muscle size, strength, and bone geometry in the upper limbs of young and old men. J Gerontol A Biol Sci Med Sci. 2002 Jul;57(7): M455–9.

    PubMed  CAS  Google Scholar 

  107. 107.

    Judex S, Gross TS, Zernicke RF. Strain gradients correlate with sites of exercise-induced bone-forming surfaces in the adult skeleton. J Bone Miner Res. 1997 Oct;12(10): 1737–45.

    PubMed  CAS  Google Scholar 

  108. 108.

    Hsieh YF, Robling AG, Ambrosius WT, Burr DB, Turner CH. Mechanical loading of diaphyseal bone in vivo: the strain threshold for an osteogenic response varies with location. J Bone Miner Res. 2001 Dec;16(12): 2291–7.

    PubMed  CAS  Google Scholar 

  109. 109.

    Nelson ME, Fiatarone MA, Morganti CM, Trice I, Greenberg RA, Evans WJ. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. JAMA. 1994 Dec 28;272(24): 1909–14.

    PubMed  CAS  Google Scholar 

  110. 110.

    Vincent KR, Braith RW. Resistance exercise and bone turnover in elderly men and women. Med Sci Sports Exerc. 2002 Jan;34(l): 17–23.

    PubMed  Google Scholar 

  111. 111.

    Bassey EJ, Rothwell MC, Littlewood JJ, Pye DW. Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise. J Bone Miner Res. 1998 Dec;13(12): 1805–13.

    PubMed  CAS  Google Scholar 

  112. 112.

    Villareal DT, Steger-May K, Schechtman KB, Yarasheski KE, Brown M, Sinacore DR, Binder EF. Effects of exercise training on bone mineral density in frail older women and men: a randomised controlled trial. Age Ageing. 2004 May;33(3): 309–12.

    PubMed  Google Scholar 

  113. 113.

    Frost HM. Skeletal structural adaptations to mechanical usage (SATMU): 4. Mechanical influences on intact fibrous tissues. Anat Rec. 1990 Apr;226(4): 433–9.

    PubMed  CAS  Google Scholar 

  114. 114.

    Villareal DT, Binder EF, Yarasheski KE, Williams DB, Brown M, Sinacore DR, Kohrt WM. Effects of exercise training added to ongoing hormone replacement therapy on bone mineral density in frail elderly women. J Am Geriatr Soc. 2003 Jul;51(7): 985–90.

    PubMed  Google Scholar 

  115. 115.

    Judge JO, Lindsey C, Underwood M, Winsemius D. Balance improvements in older women: effects of exercise training. Phys Ther 1993;73: 254–65.

    PubMed  CAS  Google Scholar 

  116. 116.

    Wolf SL, Barnhart HX, Kutner NG, et al. Reducing frailty and falls in older persons: an investigation of Tai Chi and computerized balance training. J Am Geriatr Soc 1996;44: 489–97.

    PubMed  CAS  Google Scholar 

  117. 117.

    Sattin RW, Easley KA, Wolf SL, Chen Y, Kutner MH. Reduction in fear of falling through intense tai chi exercise training in older, transitionally frail adults. J Am Geriatr Soc. 2005 Jul;53(7): 1168–78.

    PubMed  Google Scholar 

  118. 118.

    Wickham C, Walsh K, Cooper C, et al. Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ 1989;299: 889–92.

    PubMed  CAS  Google Scholar 

  119. 119.

    Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994;331: 821–7.

    PubMed  CAS  Google Scholar 

  120. 120.

    Fiatarone MA, O’Neill EF, Ryan ND, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994;330: 1769–75.

    PubMed  CAS  Google Scholar 

  121. 121.

    Rubenstein LZ, Josephson KR, Trueblood PR, Loy S, Harker JO, Pietruszka EM, Robbins AS. Effects of a group exercise program on strength, mobility, and falls among fall-prone elderly men. J Gerontol A Biol Sci Med Sci. 2000 Jun;55(6): M317–21.

    PubMed  CAS  Google Scholar 

  122. 122.

    Bonnefoy M, Cornu C, Normand S, Boutitie F, Bugnard F, Rahmani A, Lacour JR, Laville M. The effects of exercise and protein-energy supplements on body composition and muscle function in frail elderly individuals: a long-term controlled randomised study. Br J Nutr. 2003;89: 731–9.

    PubMed  CAS  Google Scholar 

  123. 122.

    Volpi E, Sheffield-Moore M, Rasmussen BB, Wolfe RR. Basal muscle amino-acid kinetics and protein synthesis in healthy young and older men. JAMA. 2001; 286: 1206–1212.

    PubMed  CAS  Google Scholar 

  124. 123.

    Morais JA, Chevalier S, Gougeon R. Protein turnover and requirements in the healthy and frail elderly. J Nutr Healthy Aging. 2006 Jul–Aug;10(4): 272–83.

    CAS  Google Scholar 

  125. 124.

    Borst SE. Intervention for sarcopenia and muscle weakness in older people. Age Ageing. 2004;33: 548–555.

    PubMed  Google Scholar 

  126. 125.

    Cederholm T, Hedstrom M. Nutritional treatment of bone fracture. Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4): 377–81.

    PubMed  CAS  Google Scholar 

  127. 126.

    Oliver D, Connelly JB, Victor CR, Shaw FE, Whitehead A, Genc Y, Vanoli A, Martin FC, Gosney MA. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ. 2007 Jan 13;334(7584): 82.

    PubMed  Google Scholar 

  128. 127.

    Parker MJ, Gillespie WJ, Gillespie LD. Effectiveness of hip protectors for preventing hip fractures in elderly people: systematic review. BMJ. 2006 Mar 11;332(7541): 571–4.

    PubMed  Google Scholar 

  129. 128.

    Kiel DP, Magaziner J, Zimmerman S, Ball L, Barton BA, Brown KM, Stone JP, Dewkett D, Birge SJ. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA. 2007 Jul 25;298(4): 413–22.

    PubMed  CAS  Google Scholar 

  130. 129.

    Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hercberg S, Meunier PJ. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int. 1997;7(5): 439–43.

    PubMed  CAS  Google Scholar 

  131. 130.

    Vecino-Vecino C, Gratton M, Kremer R, Rodriguez-Manas L, Duque G. Seasonal variance in serum levels of vitamin d determines a compensatory response by parathyroid hormone: study in an ambulatory elderly population in Quebec. Gerontology. 2006;52(1): 33–9.

    PubMed  CAS  Google Scholar 

  132. 131.

    Fardellone P, Brazier M, Kamel S, Guéris J, Graulet AM, Liénart J, Sebert JL. Biochemical effects of calcium supplementation in postmenopausal women: influence of dietary calcium intake. Am J Clin Nutr. 1998;67: 1273–8.

    PubMed  CAS  Google Scholar 

  133. 132.

    Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R, Whedon GD Vitamin D and bone health in the elderly. Am J Clin Nutr, 1982, 36, 1014–31.

    PubMed  CAS  Google Scholar 

  134. 133.

    Chapuy MC, Arlot ME, Duboeuf F, Bran J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med. 1992 Dec 3;327(23): 1637–42.

    PubMed  CAS  Google Scholar 

  135. 134.

    Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA; RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005 May 7–13;365(9471): 1621–8.

    PubMed  CAS  Google Scholar 

  136. 135.

    Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O’Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women’s Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16;354(7): 669–83.

    PubMed  CAS  Google Scholar 

  137. 136.

    Boirie Y, Gachon P, Beaufrere B. Splanchnic and whole-body leucine kinetics in young and elderly men. Am J Clin Nutr. 1997; 65: 489–95.

    PubMed  CAS  Google Scholar 

  138. 137.

    Volpi E, Ferrando AA, Yeckel CW, et al. Exogenous amino-acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 1998; 101: 2000–7.

    PubMed  CAS  Google Scholar 

  139. 138.

    Volpi E, Mittendorfer B, Wolf SE, Wolfe RR. Oral amino acids stimulate muscle protein anabolism in the elderly despite higher first-pass splanchnic extraction. Am J Physiol 1999;277: E513–20.

    PubMed  CAS  Google Scholar 

  140. 139.

    Visser M, Deeg DJ, Lips P; Longitudinal Aging Study Amsterdam. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003 Dec;88(12): 5766–72.

    PubMed  CAS  Google Scholar 

  141. 140.

    Rolland YM, Perry HM 3rd, Patrick P, Banks WA, Morley JE. Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci. 2007 Mar;62(3): 330–5.

    PubMed  Google Scholar 

  142. 141.

    Stein MS, Wark JD, Scherer S, Walton SL, Chick P, Carlantonio MD, Zajac JD, Flicker L Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostel. J Am Geriatr Soc. 1999;47: 1195–1201.

    PubMed  CAS  Google Scholar 

  143. 142.

    Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, Kendler DL, McClung MR, Miller PD, Olszynski WP, Orwoll E, Yuen CK. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev. 2005 Aug;26(5): 688–703.

    PubMed  CAS  Google Scholar 

  144. 143.

    Gerdhem P, Ringsberg KA, Obrant KJ, Akesson K. Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women. Osteoporos Int. 2005 Nov;16(11): 1425–31.

    PubMed  CAS  Google Scholar 

  145. 144.

    Greenspan SL, Schneider DL, McClung MR, Miller PD, Schnitzer TJ, Bonin R, Smith ME, DeLucca P, Gormley GJ, Melton ME. Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002 May 21;136(10): 742–6.

    PubMed  CAS  Google Scholar 

  146. 145.

    Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM, Hoszowski K, Varela AR, Fiore C, Brixen K, Reginster JY, Boonen S. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res. 2006 Jul;21(7): 1113–20.

    PubMed  CAS  Google Scholar 

  147. 146.

    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002 Jul 17;288(3): 321–33.

    PubMed  CAS  Google Scholar 

  148. 147.

    Villareal DT, Binder EF, Williams DB, Schechtman KB, Yarasheski KE, Kohrt WM. Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial. JAMA. 2001 Aug 15;286(7): 815–20.

    PubMed  CAS  Google Scholar 

  149. 148.

    Kohrt WM, Snead DB, Slatopolsky E, Birge SJ Jr. Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J Bone Miner Res. 1995 Sep;10(9): 1303–11.

    PubMed  CAS  Article  Google Scholar 

  150. 149.

    Jacobsen DE, Samson MM, Kezic S, Verhaar HJJ. Postmenopausal HRT and tibolone in relation to muscle strength and body composition. Maturitas. 2007;58(1): 7–18.

    PubMed  CAS  Google Scholar 

  151. 150.

    Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML, Delamarch P. Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc 2003;35: 439–43.

    PubMed  CAS  Google Scholar 

  152. 151.

    Wiik A, Ekman M, Morgan G, Johansson O, Jansson E, Esbjörnsson M. Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue. Histochem Cell Biol 2005;124: 161–5.

    PubMed  CAS  Google Scholar 

  153. 152.

    Hansdottir H, Franzson L, Prestwood K, Sigurdsson G. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities. J Am Geriatr Soc. 2004 May;52(5): 779–83.

    PubMed  Google Scholar 

  154. 153.

    Morley JE, Kaiser EE, Perry HM 3rd, Patrick P, Morley PM, Stauber PM, Vellas B, Baumgartner RN, Garry PJ. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997 Apr;46(4): 410–3.

    PubMed  CAS  Google Scholar 

  155. 154.

    Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996; 335: 1–7.

    PubMed  CAS  Google Scholar 

  156. 155.

    Percheron G, Hogrel JY, Denot-Ledunois S, Fayet G, Forette F, Baulieu EE, Fardeau M, Marini JF; Double-blind placebo-controlled trial. Effect of 1-year oral administration of dehydroepiandrosterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double-blind placebo-controlled trial. Arch Intern Med. 2003 Mar 24;163(6): 720–7.

    PubMed  CAS  Google Scholar 

  157. 156.

    Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanan C. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf). 1991 Jul;35(l): 47–54.

    CAS  Google Scholar 

  158. 157.

    Yeo AL, Levy D, Martin FC, Sonksen P, Sturgess I, Wheeler MM, Young A. Frailty and the biochemical effects of recombinant human growth hormone in women after surgery for hip fracture. Growth Horm IGF Res. 2003 Dec;13(6): 361–70.

    PubMed  CAS  Google Scholar 

  159. 158.

    Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev. 1993 Feb;14(1): 20–39.

    PubMed  CAS  Google Scholar 

  160. 159.

    Takala J, Ruokonen E, Webster NR. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341: 785

    PubMed  CAS  Google Scholar 

  161. 160.

    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001 Feb 14;285(6): 785–95.

    Google Scholar 

  162. 161.

    Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, Orwoll ES; Osteoporotic Fractures in Men Research Group. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc. 2007 Aug;55(8): 1216–23

    PubMed  Google Scholar 

  163. 162.

    Purser JL, Kuchibhatla MN, Fillenbaum GG, Harding T, Peterson ED, Alexander KP. Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc. 2006 Nov;54(11): 1674–81.

    PubMed  Google Scholar 

  164. 163.

    Ble A, Cherabini A, Volpato S, Bartali B, Walston JD, Windham BG, Bandinelli S, Lauretani F, Guralnik JM, Ferracci L. Lower plasma vitamin E levels are associated with the frailty syndrome: the InCHIANTI study. J Gerontol Bio Sci Med Sci 2006;61A: 278–283.

    CAS  Google Scholar 

  165. 164.

    Woods NF, LaCroix AZ, Gray SL, Aragaki A, Cochrane BB, Brunner RL, Masaki K, Murray A, Newman AB. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc 2005;53: 1321–1330.

    PubMed  Google Scholar 

  166. 165.

    Ottenbacher KJ, Ostir GV, Peek MK, Snih SA, Raji MA, Markides KS. Frailty in older Mexican Americans. J Am Geriatr Soc 2005;53(9): 1524–1531.

    PubMed  Google Scholar 

  167. 166.

    Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hébert R, Hogan DB, Wolfson C, McDowell I. Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci. 2004 Dec;59(12): 1310–7.

    PubMed  Google Scholar 

  168. 167.

    Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Vellas B, Albarede JL, Grandjean H. Instrumental activities of daily living as a potential marker of frailty: a study of 7364 community-dwelling elderly women (the EPIDOS study). J Gerontol A Biol Sci Med Sci. 2001 Jul;56(7): M448–53.

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Y. Rolland.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rolland, Y., van Kan, G.A., Benetos, A. et al. Frailty, osteoporosis and hip fracture: Causes, consequences and therapeutic perspectives. J Nutr Health Aging 12, a319–a330 (2008). https://doi.org/10.1007/BF02982665

Download citation

Keywords

  • Bone Mineral Density
  • Osteoporosis
  • Fracture Risk
  • Strontium Ranelate
  • Frailty Syndrome